Skip to main content
. 2022 May 3;13:180. doi: 10.1186/s13287-022-02848-6

Table 3.

Summary of adverse events

Treatment emergent adverse events UC-MSCS (N = 45) Placebo (N = 46)
Cerebral infarction 1 (2.22%) 0
Femoral neck fracture caused by accident 1 (2.22%) 0
Positive IAA 0 1 (2.27%)
Hyperplastic anemia 0 1 (2.27%)
Papillary thyroid carcinoma 0 1 (2.27%)
Prostate cancer 0 1 (2.27%)